Clinical application of this study was to identify the level of GSK‐3β or PP2A in a biopsy sample or in an endoscopic ultrasound‐guided fine‐needle aspiration sample before giving FUT‐175 to patients with pancreatic cancer. This evidence concerns the gene PTPA and familial pancreatic carcinoma.